Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 7/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.79 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MKNK1 | Q9BUB5 | 4/20 | 0.57 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.57 |
| ▸ | KIF11 | P52732 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29626674 | 1.00 | CYP2A6 (0.79) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| Hydrochloric Acid SCHEMBL4879355 | 0.97 | CYP2A6 (0.75) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| Ammonia Solution, Strong SCHEMBL11970110 | 0.97 | CYP2A6 (0.75) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| SCHEMBL12070033 | 0.93 | CYP2A6 (0.68) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| SCHEMBL12068188 | 0.93 | CYP2A6 (0.68) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| SCHEMBL19817613 | 0.91 | CYP2A6 (0.65) | CYP2A6CYP3A4ALDH1A1CYP1A2NOTUM | |
| SCHEMBL24534338 | 0.89 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL13907273 | 0.89 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL11577671 | 0.89 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL29360677 | 0.89 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12195446-B2 | Heteroaryl compounds and their use as therapeutic drugs | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-01-14 | — | — | US | claimed |
| US-12162813-B2 | Process for preparing 3,3,3-trifluoroprop-1-ene | THE CHEMOURS COMPANY FC, LLC (US) | 2024-12-10 | — | — | US | claimed |
| EP-3792256-B1 | PYRIDINE COMPOUNDS AS PI3K-GAMMA INHIBITORS | INCYTE CORP (US) | 2024-10-23 | — | — | EP | claimed |
| CN-116082310-B | Bipyridine amide derivative, and preparation and application thereof | 厦门大学 | 2024-08-20 | — | — | CN | claimed |
| EP-3842476-B1 | POLYMER, COMPOSITION, ELECTROCHROMIC ELEMENT, DIMMING DEVICE, AND DISPLAY DEVICE | NAT INST MATERIALS SCIENCE (JP) | 2024-02-28 | — | — | EP | claimed |
| US-20230406790-A1 | PROCESS FOR PREPARING 3,3,3-TRIFLUOROPROP-1-ENE | THE CHEMOURS COMPANY FC, LLC. (US) | 2023-12-21 | — | — | US | claimed |
| CN-116082310-A | Bipyridine amide derivative, and preparation and application thereof | 厦门大学 | 2023-05-09 | — | — | CN | claimed |
| EP-3707143-B9 | NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS | ONCOSTELLAE S L (ES) | 2023-04-12 | — | — | EP | claimed |
| US-20230002353-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | DONG A SOCIO HOLDINGS CO LTD (KR) | 2023-01-05 | — | — | US | claimed |
| EP-3707143-B1 | NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS | ONCOSTELLAE S L (ES) | 2022-12-28 | — | — | EP | claimed |
| EP-0981549-B2 | USE OF AN INHIBITOR SUBSTANCE FOR THE IMPROVEMENT OF NEURONAL REGENERATION | NEURAXO BIOPHARMACEUTICALS GMB (DE) | 2007-06-27 | — | — | EP | claimed |
| WO-2007048846-A1 | USE OF IRON-CHELATING COMPOUNDS, CYCLIC ADENOSINE MONOPHOSPHATE-INCREASING COMPOUNDS OR COMBINATIONS THEREOF FOR TREATING AXONAL LESIONS IN THE CNS | NEURAXO BIOPHARMACEUTICALS GMBH (DE) | 2007-05-03 | — | — | WO | claimed |
| EP-1466593-A1 | Biodegradable injectable implant | MCS Micro Carrier Systems GmbH (DE) | 2004-10-13 | — | — | EP | claimed |
| EP-0981549-B1 | USE OF AN INHIBITOR SUBSTANCE FOR THE IMPROVEMENT OF NEURONAL REGENERATION | NEURAXO BIOTEC GMBH (DE) | 2002-09-25 | — | — | EP | claimed |
| US-20020115598-A1 | METHOD FOR THE IMPROVEMENT OF NEURONAL REGENERATION | NEURAXO-BIOTEC GMBH (DE) | 2002-08-22 | — | — | US | claimed |
| EP-0981549-A1 | A METHOD FOR THE IMPROVEMENT OF NEURONAL REGENERATION | Müller, H.W., Prof. Dr. (DE) | 2000-03-01 | — | — | EP | claimed |
| WO-1998051708-A1 | A METHOD FOR THE IMPROVEMENT OF NEURONAL REGENERATION | MUELLER H W (DE) | 1998-11-19 | — | — | WO | claimed |
| EP-0878480-A1 | A method for the improvement of neuronal regeneration | Müller, H.W., Prof. Dr. (DE) | 1998-11-18 | — | — | EP | claimed |
| US-4061638-A | Organocalciumpyridine-type polymerization initiators | PHILLIPS PETROLEUM COMPANY (US) | 1977-12-06 | — | — | US | claimed |
| US-3997708-A | ADDITION | PHILLIPS PETROLEUM COMPANY (US) | 1976-12-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195446-B2 | Heteroaryl compounds and their use as therapeutic drugs | MERTK, ERBB2, SRC | CYP2A6 2250/4885CYP3A4 1547/4885ALDH1A1 3115/4885 |
| US-12162813-B2 | Process for preparing 3,3,3-trifluoroprop-1-ene | SULT1E1, FIP1L1, GTF3C3 | CYP2A6 872/4885CYP3A4 245/4885ALDH1A1 758/4885 |
| US-20230406790-A1 | PROCESS FOR PREPARING 3,3,3-TRIFLUOROPROP-1-ENE | SULT1E1, FIP1L1, GTF3C3 | CYP2A6 872/4885CYP3A4 245/4885ALDH1A1 758/4885 |
| US-20230002353-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | MERTK, ERBB2, SRC | CYP2A6 2250/4885CYP3A4 1547/4885ALDH1A1 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.